GlaxoSmithKline (Poland)

Recent papers from GlaxoSmithKline (Poland)

1. Medical Unmet Needs in Uncontrolled Asthma Despite GINA Step 4/5 Treatment in PolandJournal of Asthma and Allergy · 2026
2. Optimising Pharmacovigilance Efficiency with MLIT (Machine Learning for Intelligent Triage): A Tool for Statistical Safety AlertsDrug Safety · 2026
3. PFS2 outcomes by prior therapy from DREAMM-8: A phase 3 study assessing belantamab mafodotin (belamaf), pomalidomide, and dexamethasone (BPd) vs pomalidomide, bortezomib, and dexamethasone (PVd) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).Journal of Clinical Oncology · 2026
4. Long-term outcomes with sustained minimal residual disease (MRD) negativity in belantamab mafodotin–treated patients (pts) with relapsed/refractory multiple myeloma (RRMM): An update from DREAMM-8.Journal of Clinical Oncology · 2026
5. Durable clinical benefit with B-cell maturation antigen (BCMA)–directed therapy, belantamab mafodotin plus pomalidomide and dexamethasone (BPd) in relapsed/refractory multiple myeloma (RRMM): DREAMM-8 long-term responder (LTR) analysis.Journal of Clinical Oncology · 2026
6. Efficacy and Safety of Belantamab Mafodotin with Bortezomib Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: the DREAMM-6 Arm B TrialClinical Cancer Research · 2026
7. An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adultsBritish Journal of Clinical Pharmacology · 2026
8. Safety and Tolerability of Twice-Yearly Depemokimab in Patients with Asthma and Chronic Rhinosinusitis with Nasal Polyps: Pooled Results from SWIFT-1/-2 and ANCHOR-1/-2Advances in Therapy · 2025
9. The need for guardrails with large language models in pharmacovigilance and other medical safety critical settingsSHILAP Revista de lepidopterología · 2025
10. Cefuroxime axetil dosing regimens and probability of target attainment in adults and childrenBritish Journal of Clinical Pharmacology · 2025
11. Exome sequencing and analysis of 44,028 British South Asians enriched for high autozygosity2025
12. Small-cohort GWAS discovery with AI over massive functional genomics knowledge graph2024
13. Pharmacoproteomic profiling identifies secreted markers for aberrant drug action2024
14. Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trialERJ Open Research · 2024
15. An Overview of Current Statistical Methods for Implementing Quality Tolerance LimitsTherapeutic Innovation & Regulatory Science · 2023
16. The state of family business research in the Visegrád countriesJournal of Family Business Management · 2023
17. Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trialEClinicalMedicine · 2023
18. Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup RiskDrug Safety · 2023
19. Safety of SABA Monotherapy in Asthma Management: a Systematic Review and Meta-analysisAdvances in Therapy · 2022
20. Cost-effectiveness of introducing infant vaccination against pneumococcal disease in Poland – comparison of non-typeable Haemophilus influenzae protein D (PHiD-CV) and 13-valent (PCV-13) pneumococcal conjugate vaccinesJournal of Health Policy & Outcomes Research · 2022